CEO
Optigo Biotherapeutics
Optigo Biotherapeutics develops novel biotherapeutics to treat chronic ophthalmic diseases and prevent vision loss. They are focused on creating innovative treatments for debilitating eye conditions.
- Biotechnology
Updated 5 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- Optigo Biotherapeutics develops novel biotherapeutics to treat chronic ophthalmic diseases and prevent vision loss. They are focused on creating innovative treatments for debilitating eye conditions.